Each of the 12 members of the CDC’s ACIP Committee has a significant influence on the health of nearly every member of the American population.
Because they are responsible for adding to and/or altering the national vaccine schedule, it is of critical importance that they remain objective and unbiased before determining whether a new vaccination is appropriate for use, particularly in the bodies of vulnerable young children.
Unfortunately, a significant number of ACIP committee members receive direct financial returns when more vaccinations are added to the current schedule. Many own vaccination related patent(s) and/or stock shares of the pharmaceutical companies responsible for supplying new vaccines to the public.
Others receive research grant money, funding for their academic departments, or payments for the oversight of vaccine safety trials.